Search Results for

*

1-19 of 19 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Adefovir (Hepsera) for Chronic Hepatitis B Infection - STEPS - American Family Physician

Dec 15, 2003 - Adefovir offers an effective first-line alternative for the treatment of chronic hepatitis B. It also may prove to be useful in patients who have failed therapy with lamivudine as well as in patients who have difficulty tolerating interferon alfa-2b. How it compares with other agents or...

American Family Physician : STEPS

https://www.aafp.org/afp/2003/1215/p2429.html

Antibiotic Prophylaxis in Patients with Cirrhosis and Upper Gastrointestinal Bleeding -...

May 1, 2017 - Antibiotics should be used for prophylaxis in hospitalized patients with cirrhosis and upper gastrointestinal bleeding. Prophylaxis reduces all-cause mortality by 21%, as well as bacterial infections and rebleeding.

American Family Physician : FPIN's Help Desk Answers

https://www.aafp.org/afp/2017/0501/p582.html

Antiviral Drugs in the Immunocompetent Host: Part I. Treatment of Hepatitis, ...

Feb 15, 2003 - Advertisement << Previous article Next article >> Feb 15, 2003 Issue Antiviral Drugs in the Immunocompetent Host: Part I. Treatment of Hepatitis, Cytomegalovirus, and Herpes Infections RICHARD COLGAN, M.D., University of Maryland School of Medicine, Baltimore, Maryland ROBERT...

American Family Physician : Article

https://www.aafp.org/afp/2003/0215/p757.html

Caring for Pregnant Women and Newborns with Hepatitis B or C - American Family Physician

Nov 15, 2010 - Family physicians encounter diagnostic and treatment issues when caring for pregnant women with hepatitis B or C and their newborns. When hepatitis B virus is perinatally acquired, an infant has approximately a 90 percent chance of becoming a chronic carrier and, when chronically ...

American Family Physician : Article

https://www.aafp.org/afp/2010/1115/p1225.html

CDC Releases 2002 Guidelines for Treating STDs: Part II. Human Papillomavirus and ...

Nov 15, 2002 - The Centers for Disease Control and Prevention (CDC) has published the 2002 guidelines for treating sexually transmitted diseases (STDs). Information on human papillomavirus (HPV) and hepatitis is included.

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2002/1115/p1996.html

Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment - American ...

Sep 1, 2006 - Major complications of cirrhosis include ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, portal hypertension, variceal bleeding, and hepatorenal syndrome. Diagnostic studies on ascitic fluid should include a differential leukocyte count, total protein level, a ...

American Family Physician : Article

https://www.aafp.org/afp/2006/0901/p767.html

Efficacy of Direct-Acting Antivirals Compared with Older Agents for Hepatitis C - ...

Jun 1, 2017 - Although they help patients achieve sustained viralogic response, expensive direct-acting antivirals have yet to show that they can succeed in meeting top-priority treatment goals.

American Family Physician : Medicine by the Numbers

https://www.aafp.org/afp/2017/0601/od1.html

Elbasvir/Grazoprevir (Zepatier) for Hepatitis C Virus Infection - STEPS - American ...

Mar 15, 2017 - Elbasvir/grazoprevir is a safe and effective treatment for HCV genotypes 1 and 4, with or without compensated cirrhosis or HIV-1 coinfection. Patients with renal impairment, including those on hemodialysis, can use the medication.

American Family Physician : STEPS

https://www.aafp.org/afp/2017/0315/p393.html

Family Physicians Can Manage Adults with Hepatitis C - Editorials - American Family ...

Oct 1, 2018 - The Centers for Disease Control and Prevention encourages family physicians to treat patients with hepatitis C. Outcomes when primary care physicians prescribe direct-acting antivirals to patients with uncomplicated hepatitis C are comparable to those of subspecialists.

American Family Physician : Editorials

https://www.aafp.org/afp/2018/1001/p413.html

Glecaprevir/Pibrentasvir (Mavyret) for the Treatment of Chronic Hepatitis C - STEPS - ...

Nov 15, 2018 - Glecaprevir/pibrentasvir is an effective treatment for any of six genotypes of HCV infection and has few adverse effects. It can be used to treat more genotypes over a shorter duration (eight weeks for patients without cirrhosis) and is substantially less expensive than other available ...

American Family Physician : STEPS

https://www.aafp.org/afp/2018/1115/p601.html

Hepatitis C (Chronic) - Clinical Evidence Handbook - American Family Physician

Jun 15, 2008 - What are the effects of interventions in treatment-naive persons with chronic infection but without liver decompensation? What are the effects of interventions to treat persons with chronic infection, but without liver decompensation, who have not responded to or relapse after ...

American Family Physician : Clinical Evidence Handbook

https://www.aafp.org/afp/2008/0615/p1724.html

Hepatitis C: Who Should We Be Treating? - Editorials - American Family Physician

Jan 15, 1999 - Advertisement << Previous article Next article >> Jan 15, 1999 Issue Editorials Hepatitis C: Who Should We Be Treating? JEFFREY T. KIRCHNER, D.O., Lancaster General Hospital, Lancaster, Pennsylvania Am Fam Physician. 1999 Jan 15;59(2):273-277. Related Article The hepatitis C virus...

American Family Physician : Editorials

https://www.aafp.org/afp/1999/0115/p273.html

Management of Hepatitis C: Evaluating Suitability for Drug Therapy - American Family ...

Mar 15, 2004 - Chronic hepatitis C virus infection is a common and serious disease. Although an estimated 2.7 million persons in the United States have this disease, most have not yet been diagnosed. Recent advances in treatment provide successful cure in 50 to 80 percent of cases. Current drug ...

American Family Physician : Article

https://www.aafp.org/afp/2004/0315/p1429.html

NIH Consensus Statement on Management of Hepatitis B - Practice Guidelines - American ...

Oct 15, 2009 - The National Institutes of Health (NIH) Consensus Development Panel has produced a report on the management of hepatitis B virus (HBV) created by independent panels of health professionals and public representatives using a systematic literature review.

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2009/1015/p884.html

Practice Guidelines - Sep 1, 2006 - American Family Physician

Sep 1, 2006 - The American Gastroenterological Association (AGA) has released a review and position statement on the management of HCV infection.

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2006/0901/p875.html

Practice Guidelines - Sep 1, 2006 - American Family Physician

Sep 1, 2006 - In 2002 the Centers for Disease Control and Prevention (CDC), the American College of Obstetricians and Gynecologists (ACOG), and the American Academy of Pediatrics (AAP) recommended universal screening of pregnant women at 35 to 37 weeks’ gestation for rectovaginal group B ...

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2006/0901/p875a.html

Preventive Strategies in Chronic Liver Disease: Part I. Alcohol, Vaccines, Toxic ...

Nov 1, 2001 - Chronic liver disease is the 10th leading cause of death in the United States. Hepatitis C virus infection is the most frequent cause of chronic liver disease and the most common indication for liver transplantation. Preventive care can significantly reduce the progression of liver ...

American Family Physician : Article

https://www.aafp.org/afp/2001/1101/p1555.html

Sofosbuvir/Velpatasvir (Epclusa) for Hepatitis C - STEPS - American Family Physician

May 15, 2017 - Sofosbuvir/velpatasvir is an effective treatment for patients with HCV and has minimal adverse effects. It is the preferred treatment for patients with genotype 2 or 3. As with other curative treatments, it is very expensive.

American Family Physician : STEPS

https://www.aafp.org/afp/2017/0515/p664.html

Weight Loss for Patients with Nonalcoholic Fatty Liver Disease - Cochrane for ...

Sep 1, 2012 - There are insufficient high-quality studies to determine patient-oriented outcomes of weight loss for the treatment of fatty liver disease. Nonetheless, weight loss remains a reasonable goal because it may reduce liver inflammation and improve comorbidities. In two of the studies ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2012/0901/p415.html

Page  1

25 50 100 results per page